This could be the year Ironwood is known for more than just Linzess

The first thing you notice when you talk to Ironwood Pharmaceutical’s CEO Peter Hecht is that his voice has an almost surfer-like quality as he casually uses words like “cool” and “wicked” to describe the properties of molecules. But it’s not long before you start to see that nothing is casual about the long-term strategy of Ironwood (Nasdaq: IRWD) in its goal to revolutionize treatments for diseases ranging from heartburn and constipation to cardiovascular disease and muscular dystrophy.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news